Full text

Turn on search term navigation

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

We compared four derivatization reagents to analyze catecholamines and amino acids by matrix-assisted laser desorption/ionization (MALDI) mass spectrometry. 2,4,6-Trimethylpyrylium tetrafluoroborate (TMPy), 2,4-diphenyl-pyranylium tetrafluoroborate (DPP-TFB), 4-(anthracen-9-yl)-2-fluoro-1-methylpyridin-1-ium iodide (FMP-10), and triphenyl pyrilium (TPP) were used as derivatization reagents that can specifically modify primary amines or hydroxy groups in target molecules. Three derivatization reagents, not including TPP, reacted with all target molecules. The derived catecholamines dopamine and L-DOPA, and the amino acids GABA and glycine, were efficiently ionized in comparison with non-derivatized targets. Comparative analysis indicated that TMPy and FMP-10 produced general increases in signal-to-noise ratios (S/N), whereas DPP and TPP produced specific increases in the S/N of GABA and DA. Notably, TMPy is a small molecule that efficiently reacts with target molecules due to the absence of high bulk and steric hinderance.

Details

Title
Comparative Analysis of Derivatization Reagents for Catecholamines and Amino Acids
Author
Taira, Shu 1 ; Ikeda, Akari 2   VIAFID ORCID Logo  ; Kobayashi, Shoko 3 ; Shikano, Hitomi 1 ; Ikeda, Ryuzoh 1 ; Maejima, Yuko 4 ; Horita, Shoichiro 4 ; Yokoyama, Jun 2 ; Shimomura, Kenju 4 

 Faculty of Food and Agricultural Sciences, Fukushima University, Kanayagawa, Fukushima 960-1248, Japan; [email protected] (H.S.); [email protected] (R.I.) 
 Taiyo Nippon Sanso Co., Tama, Tokyo 206-0001, Japan; [email protected] (A.I.); [email protected] (J.Y.) 
 Graduate School of Agricultural and Life Sciences, The University of Tokyo, Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan; [email protected] 
 Department of Pharmacology, Fukushima Medical University, Hikarigaoka 1, Fukushima 960-1295, Japan; [email protected] (Y.M.); [email protected] (S.H.); [email protected] (K.S.) 
First page
6217
Publication year
2021
Publication date
2021
Publisher
MDPI AG
e-ISSN
20763417
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2549266019
Copyright
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.